Although IL-17 and its downstream pathways have been shown to be strongly associated with the initiation and propagation of fibrosis, literature evidence suggests that this interleukin even though involved in fibrosis of most body organs in the course of SSc, does not exert an influence on the kidney [6]. This evidence concerns the gene IL17A and systemic sclerosis.